Crossmark

Transcutaneous bilirubinometer use and practices surrounding jaundice in 150 California newborn intensive care units

Crossref DOI link: https://doi.org/10.1038/s41372-018-0154-3

Published Online: 2018-08-17

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bhatt, Dilip R.

Kristensen-Cabrera, Alexandria I.

Lee, Henry C. https://orcid.org/0000-0001-8383-1720
Weerasinghe, Sunjeeve

Stevenson, David K.

Bhutani, Vinod K.

Maisels, M. Jeffrey

Ramanathan, Rangasamy https://orcid.org/0000-0002-7358-601X
License Information

Text and Data Mining valid from 2018-08-17
More Information

Article History

Received: 5 September 2017

Revised: 10 April 2018

Accepted: 17 May 2018

First Online: 17 August 2018

Compliance with ethical standards

:

: M. Jeffrey Maisels is a consultant to Draeger Inc (Telford, PA), the supplier of the JM-103 and JM-105 transcutaneous bilirubinometers. The remaining authors declare no conflicts of interest.